Page last updated: 2024-09-04

allotrap and trinitrobenzenesulfonic acid

allotrap has been researched along with trinitrobenzenesulfonic acid in 1 studies

Compound Research Comparison

Studies (allotrap)	Trials (allotrap)	Recent Studies (post-2010) (allotrap)	Studies (trinitrobenzenesulfonic acid)	Trials (trinitrobenzenesulfonic acid)	Recent Studies (post-2010) (trinitrobenzenesulfonic acid)
29	3	1	2,710	10	1,042

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bourreille, A; Buelow, R; de la Blétière, DR; Doubremelle, M; Galmiche, JP; Segain, JP; Toquet, C	1

Trials

1 trial(s) available for allotrap and trinitrobenzenesulfonic acid

Article	Year
RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease. Scandinavian journal of gastroenterology, 2003, Volume: 38, Issue:5 Topics: Adolescent; Adult; Aged; Animals; Anti-Inflammatory Agents; Colitis; Crohn Disease; Female; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Interleukin-1; Intestinal Mucosa; Male; Middle Aged; Models, Animal; Peptides; Prospective Studies; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2003

Article

Year

RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.

Scandinavian journal of gastroenterology, 2003, Volume: 38, Issue:5

Topics: Adolescent; Adult; Aged; Animals; Anti-Inflammatory Agents; Colitis; Crohn Disease; Female; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Interleukin-1; Intestinal Mucosa; Male; Middle Aged; Models, Animal; Peptides; Prospective Studies; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2003